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Two peptidases which convert r2’I-Lys-Arg-ME and 12’1-ME-Arg6, respectively, to “‘I-ME, have been 
identified and characterized in bovine adrenomedullary chromaffin granules. The former is referred to as 
a secretory granule peptidase (SGP) and the latter as a carboxypeptidase B-like enzyme (CPB-like) [7] 
which is here further characterized. SGP cleaved ‘251-Lys-Arg-ME to produce only 12*I-ME and was 
localized in chromaffin granules which contained Co’+ -stimulated CPB-like activity, ME, and 
catecholamines. Both the SGP and the CPB-like enzymes appear to be thiol-metalloproteases. While the 
CPB-like enzyme seems likely to be involved in processing the enkephalin precursors [7], SGP may 
function as a trypsin-like or aminopeptidase nzyme in secretory granules. 
Limited proteolysis Secretory granule Proenkephalin 
1. INTRODUCTION 
Secretory granules in peptidergic cells syn- 
thesize, store, and release small peptides and 
neurotransmitters as extracellular chemical 
messengers. These granules should contain a 
trypsin-like endopeptidase which cleaves on the 
carboxyl terminal side of basic amino acid residues 
and a carboxypeptidase B-like (CPB-like) enzyme 
which removes C-terminal lysine or arginine 
residues for processing hormone precursors into 
their mature forms. Indeed, secretory granule 
trypsin-like enzymes have been found that cleave 
proinsulin [l-3] and POMC (proopiomelanocor- 
tin) [4-61. CPB-like enzymatic activities which 
may be involved in the processing of pro- 
Abbreviations: ME, methionine enkephalin; BzlSA, 
benzylsuccinic acid; APMSA, aminomercaptosuccinic 
acid; GPSA, guanidinopropylsuccinic acid; PMSF, 
phenylmethylsulfonyl fluoride; PCMPSA, p-chloromer- 
curiphenylsulfonic acid; TLCK, tosyllysine chloro- 
methyl ketone; TLC, thin-layer chromatography 
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enkephalin and POMC or provasopressin have 
been demonstrated in chromaffin granules [7,8] 
and pituitary secretory granules [9], respectively. 
Other peptidases may be important for secretory 
granule function. Here, we describe a peptidase in 
bovine adrenomedullary chromaffin granules 
which catalyzes the conversion of ‘**I-Lys-Arg-ME 
to ‘*?-ME and refer to it as a secretory granule 
peptidase or SGP. Its possible functions are 
discussed and the CPB-like activity described in [7] 
is further characterized. 
2. MATERIALS AND METHODS 
2.1. Preparation of bovine adrenal medulla 
chromaffin granules 
Purified chromaffin granules were prepared by a 
modification of the method in [IO]. As described 
[7], purified granules were made by applying a 
crude granule preparation (10 ml in 0.32 M 
sucrose) on 1.6 M sucrose (25 ml) and centrifuging 
at 25000 rpm for 120 min in a Beckman SW-28 
rotor; the pellet contains purified chromaffin 
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granules. Centrifugation through an additional 
1.6 M sucrose gradient results in a preparation vir- 
tually free from lysosomal contamination (this 
fraction contained 0.05% of total tissue acid 
phosphatase, a lysosomal enzyme marker). The 
granules were lysed in 0.015 M KC1 at 4°C for 2 h. 
Membrane and soluble granule fractions were 
separated by centrifugation for 1 h at 10000 rpm 
in a Sorvall SS-34 rotor. For analysis of chromaf- 
fin granule and lysosomal content in the crude and 
purified granule fractions, each sample was 
layered on a multistep discontinuous sucrose gra- 
dient consisting of 4 ml each of 2.2, 2.0, 1.8, 1.6, 
1.4, 1.2, and 1.0 M sucrose and centrifuged at 
25000 rpm for 100 min in a Beckman SW-28 
rotor. Each 1 .O ml fraction from the gradient was 
assayed for ME immunoreactivity [111, catechol- 
amines [12], acid phosphatase activity [13], and 
protein [ 141. 
Analtech, Newark, DE). HVE and visualization of 
peptides by fluorescamine were performed as in 
191. 
2.3. Carboxypeptidase assay 
The conversion of “‘I-ME-Arg6 to lZ51-ME was 
measured at pH 6.0 as in [7]. 
2.4. Gel filtration column chromatography 
The soluble fraction of chromaffin granules 
(purified through one 1.6 M sucrose gradient) was 
concentrated and applied onto a Sephadex G-75 
(Pharmacia, 1.2 x 71 cm) column equilibrated in 
50 mM K-phosphate buffer (pH 6.0). Fractions of 
3 ml were collected with a flow rate of 20 ml/h, 
and aliquots of 10~1 were assayed for peptidase 
activities. 
3. RESULTS 
2.2. SGP assay for the conversion of 3.1. SGP activity in chromaffin granules 
‘251-Lys-Arg-ME to r251-ME 
Lys-Arg-ME (Peninsula Laboratory, San 
Carlos, CA) was iodinated by the chloramine-T 
method [7]. The reaction mixture contained, in a 
total volume of 20~1, 5-10 x lo-’ M 1251-Lys- 
Arg-ME, 150 mM K-phosphate (pH 7.5) and 
150 mM NaCl. Enzyme sample (10 ~1) was added 
to the reaction mixture and incubated at 37°C for 
60 min. The reaction was stopped by adding 10~1 
of 95% EtOH. Substrate and product were 
separated by TLC as described for the CPB assay 
171. Radioactivity was scanned along each lane by 
a BID 100 radiogram imaging system (Bioscan 
Inc., Washington, DC) and total cpm “‘I-ME was 
determined by computing the integral of each peak 
with an HP-85 computer. 
SGP activity for the conversion of ‘251-Lys-Arg- 
ME to 12’I-ME was present in the soluble compo- 
nent of chromaffin granules, as shown by the pro- 
duction of a single radioiodinated product which 
comigrated with 12’I-ME (fig.1). The activity was 
dependent on enzyme concentration and incuba- 
tion time, and no activity was seen at 0°C or with 
a boiled sample (not shown). Purified pancreatic 
trypsin also converted “‘1-Lys-Arg-ME to a single 
product comigrating with ‘251-ME (not shown). 
LAM M 
When Lys-Arg-ME and its products were to be 
separated by high-voltage electrophoresis (HVE), 
the SGP reaction mixture (in a volume of 20~1) 
contained 20 pg Lys-Arg-ME (non-radioactive), 
150 mM K-phosphate (pH 7.5) and 150 mM NaCl. 
The soluble fraction of chromaffin granules was 
dialyzed to remove catecholamines, which produce 
interfering fluorescence. Enzyme sample (10 ~1) 
was added to the reaction mixture (2Opl), and in- 
cubated at 37°C for 15 min to 6 h. After addition 
of 25 ~1 of 90% EtOH-10% acetic acid, samples 
were vortex mixed, kept on ice for 30 min, and 
spotted on cellulose TLC plates (Avicel, 250pm, 
Fig. 1. SGP activity for the conversion of lz51-Lys-Arg- 
ME to “‘I-ME in the soluble fraction of bovine 
adrenomedullary chromaffin granules. Activity was 
measured at pH 7.4. Substrate and products were 
separated by TLC. Arrows indicate the migration 
positions of standard “‘1-Lys-Arg-ME (LAM) and ‘251- 
ME (M). 
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SGP had optimal activity at pH 7.4-8.5, with 30% 
of optimum activity present at pH 6.0. No activity 
was found in the membrane fraction (not shown). 
To determine whether the cleavage occurred bet- 
ween the Arg-Tyr residues or if removal of Lys is 
followed rapidly by removal of Arg, substrate and 
products were separated on the basis of their dif- 
ferential charge by HVE (fig.2). Standard migra- 
tion positions of Lys-Arg, Lys, Arg, Lys-Arg-ME, 
and ME show that the majority of these species 
could be separated by HVE. The migration posi- 
tions of standard Lys and Arg overlapped with one 
another; therefore, ~uorescamine-labelled spots 
comigrating with Lys or Arg were referred to as a 
mixture of Lys/Arg. Incubation of Lys-Arg-ME 
with the soluble granule fraction for 4 h followed 
by HVE resulted in the visualization of 3 
fluorescamine-positive spots (fig.3): one migrating 
with Lys/Arg, one with ME, and one, presumabIy 
AM I 
p000 
I 1 I 1 
1 23456789 
Fig.2. Cleavage of Lys-Arg-ME by soluble fraction of 
bovine adrenomedullary chromaffin granuies. Substrate 
and cleavage products were separated by MVE on 
cellulose TLC plates. Electrophoresis was run at 800 V 
until the methyl green (MG) marker dye migrated 12 cm 
from the origin. Migration position of standards: lane I, 
lysine (L); lane 2, arginine (A); lane 3, Lys-Arg (LA); 
lane 4, Lys-Arg-ME (LAM}; lane 5, ME (M). LAM was 
incubated with 1 ,ug pancreatic trypsin for 15 min (lane 
6) and 1 h (lane 7). and incubated with the soluble 
fraction of purified chromaffin granules for 4 h (lane 8) 
and for 6 h (lane 9). In lane 6, since free Lys was 
liberated, the other expected product would be Arg-ME, 
indicated by AM, which would be predicted to migrate 
to a smaller Rf than LAM based on their differential 
charge. 
Arg-ME, which migrated between ME and Lys- 
Arg-ME. Further incubation for 6 h resulted in 
complete conversion of Lys-Arg-ME to ME and 
Lys/Arg; no spot corresponding to the dipeptide 
Lys-Arg was visualized. An identical pattern was 
seen with purified pancreatic trypsin. The forma- 
tion of Arg-ME and free LyslArg suggests that the 
soluble fraction of chromaffin granules, like the 
purified pancreatic trypsin, removed the N- 
terminal basic residues sequentially. 
3.2, Sucrose density gradient fractionation of 
SGP and CPB-like activities 
To determine whether the SGP and CPB-Iike ac- 
tivities reside uniquely in chromaffin granules, a 
preparation of crude chromaffin granules and 
purified granules (crude granules purified through 
one 1.6 M discontinuous sucrose gradient) was 
fractionated on a multistep sucrose gradient of 
2.2-1 .O M sucrose. Chromaffin granules were 
found to make up the major part of the crude 
granule preparation, but there is a small lysosomal 
contamination (fig.3). SGP- and CPB-like ac- 
tivities were present in ME and catechoiamine- 
containing granule fractions (fig.4). Co2+-stimu- 
lated CPB-like activity was associated with the 
granular but not the lysosomal fractions, as 
reported in 181. Protease in the lysosomal frac- 
tions cleaved rz51-Lys-Arg-ME (not shown) and 
r2’I-ME-Arg6 [7] substrates to many unidentified 
radioiabelled substances in addition to r2$ME. 
Only the granule enzymes cleaved the substrates to 
produce ME exclusively. 
Sucrose gradient analysis of purified granules 
(fig.3) shows that lysosomal contamination has 
been removed, and SGP and Co’“-stimulated 
CPB-like activities remained with the granule frac- 
tions. The large amount of enzyme activities, ME, 
catecholamines, and protein in fractions 31-34 
was probably due to the presence of some lysed 
granules. 
3.3. &ope&es of SGP and CPB-like activities 
The effect of several protease inhibitors on SGP 
and CPB-like activities was studied (table 1). The 
soluble fraction of granules purified through two 
1.6 M discontinuous sucrose gradients was used 
here since this fraction contained large amounts of 
both enzymes. Thiol reagents such as Cu” and 
PCMPSA [15], inhibited both enzyme activities. 
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Fig.3. Sucrose density gradient fractionation of crude and purified chromaffin granules from bovine adrenal medulla. 
Crude (panel 1) or purified (panel II) chromaffin granules were fractionated on a multi-step sucrose gradient (2.2-l .O M 
sucrose). Each fraction was measured for: (A) SGP and CPB-like activities; (B) catecholamine and ME content; (C) 
acid phosphatase activity and protein content. 
Both enzymes were inhibited by the metal chelators metalloprotease inhibitors was not originally ap- 
1,lOphenanthroline and EDTA. SGP activity was paren: [7]; this may be due to the present use of 
inhibited by Ni2+, Cd2+, and Co’+, while the CPB- “‘1-ME-Arg6 with higher specific activity and a 
like activity was stimulated by Co2+ (81 and in- Bioscan 100 imaging system with greater resolu- 
hibited by the Zn-metallocarboxypeptidase in- tion, resulting in a more sensitive enzyme assay. 
hibitors BzlSA, APMSA, GPSA, and the potato Lack of inhibition by PMSF and TLCK suggests 
inhibitor [l&18]. The effect of the Zn- that neither enzyme is a serine protease. 
9 12 15 la 21 24 27 30 36 39 
Figd. Sephadex G-75 column chromatography of 
soluble fraction from chromaffin granules: SGP and 
Co’+-stimulated CPB-like activities. 
SGP- and CPB-like activities in adrenal medulla 
chromaffin granules and lysosomes were com- 
pared. The lysosomal SGP-like activity was in- 
hibited by antipain but the granule enzyme was on- 
ly slightly inhibited. Chloroquine had no effect on 
the granule CPB-like activity but somewhat in- 
hibited lysosomal carboxypeptidase. Co2’ stimu- 
lated the granule CPB but had no effect on the 
Iysosomal activity. 
The soluble fraction of chromaffin granules was 
chromatographed on a Sephadex G-75 gel filtra- 
tion column (fig.4). SGP and Co’+-stimulated 
CPB-like activities eluted from the column as 
separate peaks with apparent MI values of approx. 
55000-60000 and 40000-50000, respectively. 
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Table 1 
Effect of inhibitors and activators on SGP and CPB activities in chromaffin granules and Iysosomes 
from bovine adrenal medulla 
Inhibitor Concentration Enzyme activity (070 control, x rt SE) 
Chromaffin granules 
SGP CPB 
Lysosomes 
SGP-like CPB-like 
None 
PCMPSA 
cuc12 
1 ,lO-Phenanthroline 
EDTA 
Potato inhibitor 
BzlSA 
APMSA 
GPSA 
coc12 
CdClz 
PbClz 
NiCl2 
ZnS04 
PMSF 
TLCK 
Soybean trypsin inhibitor 
Ovoinhibitor 
Aprotinin 
Leupeptin 
Antipain 
Chloroquine 
- 
4.1 x 1o-4 
1.4 x 1o-4 
1.4 x lo-3 
1.4 x 1o-4 
4.6 x lo-’ 
1.4 x 1o-4 
2.8 x 1O-4 
6.4 x 1O-4 
1.4 x lo-’ 
1.4 x 1o-4 
1.4 x 1o-4 
1.4 x 1o-4 
1.4 x 10-j 
1.4 x 1o-4 
1.4 x 1o-4 
0.1 mg/ml 
14 g/ml 
0.35 mg/ml 
3.7 x 1o-3 
2.1 x 1o-3 
1.4 x 1o-4 
100 
23 f 5” 
llf 3a 
16% 8a 
6-I +_ 6a 
922 7 
88-t 3 
97* 4 
965 3 
41+ 6a 
58 f lOa 
93* 2 
34 + 10” 
lOOk 5 
101 + 6 
106t 3 
96+ 2 
1OOt 1 
106+_ 6 
102-+ 2 
go* 7 
101 -+ 6 
100 
10 _+ 38a 
13 + la 
57 +_ 18” 
71 + 13” 
82 + 3” 
69 + 10” 
57 + 13a 
40 f 8a 
205 + 43a 
81-t 5 
95* 1 
915 9 
96+ 6 
100 1+_ 10 
120 _+ 40 
100 
44 -t 2oa 
25 -t 23a 
17 +- 17a 
51 +48 
82 + 21 
99_t 3 
96& 2 
102 ?I 13 
67 + 2” 
36 +- 19” 
93-t 7 
42 +- 24a 
38 + 50 
72 it 21 
79 + 31 
83 + 20 
76 + 39 
32 + 4a 
70 f 28 
100 
29 rtr 8a 
28 + 10” 
82s 11 
88* 3 
992 8 
36 _+ 6” 
94 f 10 
54 + la 
94+ 9 
85 + 10 
94t 11 
92+ 7 
61 +- 16a 
59 + 13a 
69 -+ lla 
Protease inhibitors (5 ~1) and enzyme sample (10~1) sat on ice for 30 min before the addition of the 
reaction mixture. Purified potato carboxypeptidase inhibitor was a gift from Dr M. Hass, University 
of Idaho. GPSA, APMSA, and BzlSA were gifts from Dr T.H. Plummer, New York Department of 
Public Health. Chromaffin granules, n = 3, a statistically significant, p < 0.05 (f-test). Lysosomes, n = 
2, a statistically significant, p < 0.10 (r-test). Concentrations of inhibitors given as M unless stated 
otherwise 
4. DISCUSSION 
Purified bovine adrenal medullary chromaffin 
granules contain a peptidase (SCP) that converts 
lz51-Lys-Arg-ME to “‘I-ME. These granules con- 
tain ME, catecholamines, and the CPB-like pro- 
cessing enzyme that we described in [7]. Unlike the 
enzyme(s) found in lysosomes which break down 
1251-Lys-Arg-ME into many products, the granule 
SGP produces 12’I-ME exclusively. In this regard, 
SGP resembles in its specificity chromaffin granule 
CPB-like activity which generates only 1251-ME 
from ‘251-ME-Arg6. SGP and CPB-like activities 
are clearly not associated with lysosomes. Thus, 
the suggestion in [8] that the carboxypeptidase we 
have observed was due to lysosomal contamination 
of our granule preparation is incorrect. 
Inhibition by metal ion chelators and thiol 
reagents uggests that both SGP and CPB-like ac- 
tivities may be thiol-metalloproteases. The CPB- 
like activity was also inhibited by zinc 
metalloprotease inhibitors (BzlSA, APMSA, and 
GPSA) and was stimulated by Co’+ [8]. However, 
SGP was inhibited by Co2+. The enzymes do not 
seem to be tightly bound to one another, as they 
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are readily separated on Sephadex G-75 in a non- 
denaturing buffer. 
While the CPB-like enzyme seems likely to be in- 
volved in processing the enkephalin precursors 
[7,8,18], the function of SGP is presently unclear. 
SGP may be a trypsin-like enzyme, since purified 
pancreatic trypsin also converts ‘251-Lys-Arg-ME 
to ‘251-ME. Demonstration that SGP may be a 
trypsin-like enzyme must be based on the use of 
purified proenkephalin [ 1 g-211. 
SGP may be an aminopeptidase since it appears 
to remove sequentially the two N-terminal amino 
acid residues from ‘251-Lys-Arg-ME. An amino- 
peptidase could be involved in enkephalin precur- 
sor processing if the trypsin-like enzyme cleaves 
between -Lys-Arg- residues to generate enkepha- 
lins extended at their N-termini with a basic amino 
acid residue. AIthough tr~sin-Iike processing en- 
zymes are generally thought to cieave at the C- 
terminal side of Arg at Lys-Arg pairs, no ME&y.@- 
Arg7 has been found in adrenal medulla or 
striatum, regions rich in enkephalin peptides. The 
absence of Arg-ME in such regions might be ac- 
counted for by the rapid removal of the N-terminal 
Arg by an aminopeptidase. 
The properties of SGP differ from those of 
previously studied trypsin [22,23] and aminopep- 
tidase [24] enzymes. Unlike pancreatic trypsin, 
SGP is not a serine protease. In addition, SGP dif- 
fers in its M; (~~~-~~) from ~inopeptidase 
B (95 000) which cleaves NHz-terminal basic amino 
acid residues. 
It is interesting that the chromaffin granule 
CPB-like enzyme, thought to be involved in 
enkephalin precursor processing, also differs from 
other studied carboxypeptidases such as pancreatic 
CPB and plasma CPN [16,17] in its thiol 
dependence, acidic pH optimum and apparent Mr. 
Other secretory granule peptidases such as the 
trypsin-like enzymes involved in processing proin- 
sulin [l-3] and POMC [4-61, and carboxypep- 
tidases thought to be involved in processing 
POMC and provasopressin [9] differ from serine 
pancreatic trypsin and Zn-metallocarboxypepti- 
dases, respectively. Perhaps, secretory granules 
contain a set of peptidases with properties dif- 
ferent from those found in other cellular 
compartments. 
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